Vera Therapeutics (VERA) Non Operating Income (2020 - 2026)
Vera Therapeutics (VERA) posted Non Operating Income of $4.1 million for Q1 2026, up 31.83% on a QoQ basis from $3.1 million in Q4 2025, and down 25.45% year-over-year from $5.5 million in Q1 2025.
Vera Therapeutics (VERA) Non Operating Income (2020 - 2026) Analysis & Trends
Vera Therapeutics' Non Operating Income history runs 7 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- Quarterly Non Operating Income fell 25.45% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.5 million (down 18.74% YoY) and the FY2025 annual result came in at $15.9 million, up 5.56% from the prior year.
- Non Operating Income was $4.1 million for Q1 2026 at Vera Therapeutics, up from $3.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $5.5 million in Q1 2025 and bottomed at -$64000.0 in Q1 2022.
- A 5-year average of $2.5 million and a median of $2.7 million in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income plunged 3300.0% — and 2023, when it jumped 1957.81%.
- Vera Therapeutics' Non Operating Income stood at $1.1 million in 2022, then rose by 20.21% to $1.4 million in 2023, then soared by 299.56% to $5.5 million in 2024, then tumbled by 43.35% to $3.1 million in 2025, then soared by 31.83% to $4.1 million in 2026.
- Business Quant data shows VERA's Non Operating Income at $4.1 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Vera Therapeutics | 2.55 Bn | 2.55 Bn | - | 4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Dec 31, 2024 | 5.49 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 3.64 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 565,000.00 |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | -64,000.00 |
| Dec 31, 2021 | -261,000.00 |
| Sep 30, 2021 | -359,000.00 |
| Jun 30, 2021 | 2.41 Mn |